Unamed Medicine: Stock implemented with other risk warning Stock abbreviation changed to "ST Unamed"

Unimed Pharmaceutical announced that its controlling subsidiary, Unimed Tianjin, is expected to be unable to resume normal production and operation activities within three months. The company's stock trading has triggered a "other risk warning" situation. The company's stock has been suspended from trading for one day since July 7, 2025, and resumed trading from July 8, 2025. Starting from July 8, 2025, the company's stock has been subject to the "other risk warning," and the stock abbreviation has been changed from "Unimed Pharmaceutical" to "ST Unimed," with the security code still being "002581." After the implementation of the other risk warning, the daily limit for the company's stock trading has been reduced from 10% to 5%.